The Department of Genetic Medicine at Weill Cornell leads a dynamic and innovative translational research program, advancing diverse fields such as Genetic Therapy and Personalized Medicine.
Our translational research program aims to leverage our expertise in genetic therapies and personalized medicine to develop clinical solutions that target the molecular causes of human diseases.
The Department of Genetic Medicine advances treatments and diagnostics through diverse clinical trials, including drug testing and research to better understand diseases.
The Department of Genetic Medicine at Weill Cornell leads a dynamic and innovative translational research program, advancing diverse fields such as Genetic Therapy and Personalized Medicine.
Our translational research program aims to leverage our expertise in genetic therapies and personalized medicine to develop clinical solutions that target the molecular causes of human diseases.
The Department of Genetic Medicine advances treatments and diagnostics through diverse clinical trials, including drug testing and research to better understand diseases.
O'Reilly M, Kohn D, Bartlett J, Benson J, Brooks P, Byrne B, Camozzi C, Cornetta K, Crystal R, Fong Y, Gargiulo L, Gopal-Srivastava R, High K, Jacobson S, Jambou R, Montgomery M, Rosenthal E, Samulski R, Skarlatos S, Sorrentino B, Wilson J, Xie Y, Corrigan-Curay J
Journal
Hum Gene Ther
Volume
24
Issue
4
Pagination
355-62
Date Published
04/01/2013
ISSN
1557-7422
Keywords
Rare Diseases
Abstract
Gene therapy has shown clinical efficacy for several rare diseases, using different approaches and vectors. The Gene Therapy for Rare Diseases workshop, sponsored by the National Institutes of Health (NIH) Office of Biotechnology Activities and Office of Rare Diseases Research, brought together investigators from different disciplines to discuss the challenges and opportunities for advancing the field including means for enhancing data sharing for preclinical and clinical studies, development and utilization of available NIH resources, and interactions with the U.S. Food and Drug Administration.